Effects of Curcumin Administration on Nesfatin-1 Levels in Blood, Brain and Fat Tissues of Diabetic Rats

dc.contributor.author Algul, S.
dc.contributor.author Ozcelik, O.
dc.contributor.author Oto, G.
dc.contributor.author Sarikaya, M.
dc.contributor.author Goceroglu, R. T.
dc.contributor.author Embiyaoglu, N. M.
dc.contributor.author Akcan, A. G.
dc.date.accessioned 2025-05-10T17:07:59Z
dc.date.available 2025-05-10T17:07:59Z
dc.date.issued 2021
dc.description Embiyaoglu, Nuri Mert/0000-0002-1627-8539 en_US
dc.description.abstract OBJECTIVE: We evaluated the efficacy of curcumin administration on blood glucose levels and its relationship with nesfatin-1 levels in blood brain and adipose tissue of streptozotocin-induced diabetic rats. MATERIALS AND METHODS: A total of 28 male rats were divided into four groups: control group, type 2 diabetes mellitus (DM) group, control plus curcumin group and type 2DM plus curcumin group. After fifteen days, blood samples were collected from sacrificed rats. Nesftain-1 levels were analysed from blood, brain, and fat tissues of rats in all groups. RESULTS: Nesfatin-1 level was found to be significantly lower in blood, brain and fat tissues of type 2 DM rats compared to the control group. A significant decrease in fasting blood glucose levels was observed in the curcumin administration group compared to type 2 DM group. Improvement of fasting blood glucose level was accompanied by improvement of nesfatin-1 levels in blood, brain, and fat tissues. CONCLUSIONS: As expected, curcumin administration caused significant improvement in fasting blood glucose levels. However, for the first time, we found marked improvements in nesfatin-1 levels in blood, brain, and fat tissues of type 2 DM rats. Thus, considering the crucial role of nesfatin-1 in regulation of glucose metabolism, it is logical to expect an interactive relationship between curcumin and nesfatin-1. en_US
dc.description.sponsorship Van Yuzuncu Yil University Scientific Research Project Office [TLO-2019-7685] en_US
dc.description.sponsorship This study was supported by Van Yuzuncu Yil University Scientific Research Project Office (Project number: TLO-2019-7685). en_US
dc.identifier.doi 10.26355/eurrev_202102_24872
dc.identifier.issn 1128-3602
dc.identifier.scopus 2-s2.0-85101154182
dc.identifier.uri https://doi.org/10.26355/eurrev_202102_24872
dc.identifier.uri https://hdl.handle.net/20.500.14720/6930
dc.language.iso en en_US
dc.publisher verduci Publisher en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Nesfatin-1 en_US
dc.subject Curcumin en_US
dc.subject Diabetes en_US
dc.subject Streptozotocin en_US
dc.subject Rat en_US
dc.title Effects of Curcumin Administration on Nesfatin-1 Levels in Blood, Brain and Fat Tissues of Diabetic Rats en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Embiyaoglu, Nuri Mert/0000-0002-1627-8539
gdc.author.scopusid 56318101800
gdc.author.scopusid 55886751100
gdc.author.scopusid 25230277800
gdc.author.scopusid 57195476857
gdc.author.scopusid 57222050900
gdc.author.scopusid 57222039009
gdc.author.scopusid 57223042015
gdc.author.wosid Sarikaya, Mucahit/Gzk-4637-2022
gdc.author.wosid Ozcelik, Oguz/Adw-0044-2022
gdc.author.wosid Temelli̇ Göçeroğlu, Rezzan/Izp-5421-2023
gdc.author.wosid Embiyaoğlu, Nuri Mert/Grs-3441-2022
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Algul, S.; Akcan, A. G.] Van Yuzuncu Yil Univ, Fac Med, Dept Physiol, Van, Turkey; [Ozcelik, O.] Kastamonu Univ, Dept Physiol, Fac Med, Kastamonu, Turkey; [Oto, G.; Goceroglu, R. T.] Van Yuzuncu Yil Univ, Fac Med, Dept Pharmacol, Van, Turkey; [Sarikaya, M.; Embiyaoglu, N. M.; Oner, S.] Van Yuzuncu Yil Univ, Phys Educ & Sports, Van, Turkey; [Caf, F.] Bingol Univ, Tech Sci Vocat High Sch, Bingol, Turkey en_US
gdc.description.endpage 1621 en_US
gdc.description.issue 3 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 1616 en_US
gdc.description.volume 25 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 33629331
gdc.identifier.wos WOS:000619780200052
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files